康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01681 康臣药业

未开盘 06-10 16:09:07

13.910

+0.080

+0.58%

最高13.970	最低13.520	成交量157.55万
今开13.830	昨收13.830	日振幅3.25%
总市值116.84亿	流通市值116.84亿	总股本8.40亿
成交额2,166万	换手率0.19%	流通股本8.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":13.91,"timestamp":1781078947004,"preClose":13.83,"halted":0,"volume":1575492,"delay":0,"changeRate":0.005784526391901668,"floatShares":840000000,"shares":840000000,"eps":1.26,"marketStatus":"未开盘","change":0.08,"latestTime":"06-10 16:09:07","open":13.83,"high":13.97,"low":13.52,"amount":21661591,"amplitude":0.032538,"askPrice":13.92,"askSize":4000,"bidPrice":13.9,"bidSize":188000,"shortable":3,"etf":0,"ttmEps":1.402141,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781141400000},"marketStatusCode":0,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":13.83,"dividendRate":0.054535,"openAndCloseTimeList":[[1781055000000,1781064000000],[1781067600000,1781078400000]],"volumeRatio":0.873306,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681/","defaultTab":"news","newsList":[{"id":"1150182071","title":"康臣药业：6月10日回购6.70万股，耗资约92.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150182071","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150182071?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:01","pubTimestamp":1781092918,"startTime":"0","endTime":"0","summary":"康臣药业于2026年6月10日发布翌日披露报表，宣布公司于当日通过香港联交所场内交易回购普通股67,000股，约占回购前现有已发行股份的0.00797%。本次回购每股价格介乎港币13.71元至港币13.97元，合计支付约港币928,100元。回购完成后，康臣药业的已发行股本由840,385,111股减少至840,318,111股；公司的库藏股数量由1,162,000股增至1,229,000股，已发行股份总数维持在841,547,111股。公司在公告中确认，本次股份回购获得董事会正式授权，并严格遵照香港联交所证券上市规则及相关法律法规进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康臣药业：6月10日回购6.70万股，耗资约92.81万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642344460","title":"康臣药业(01681)6月9日斥资360.9万港元回购26.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642344460","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642344460?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:38","pubTimestamp":1781008690,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月9日斥资360.9万港元回购26.1万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641387107","title":"康臣药业(01681)拟收购上海华茂药业有限公司30%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2641387107","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641387107?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:40","pubTimestamp":1780908014,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业 发布公告，于2026年6月8日，公司的全资附属公司广州康臣药业有限公司与于中国上海注册成立的有限责任公司上海华茂药业有限公司及其现有股东订立投资协议。根据该协议，广州康臣将通过收购现有股权及现金增资方式，合计投资人民币19140.22万元。交易完成后广州康臣将持有目标公司30%股权。目标公司将成为公司的联营公司，其财务业绩将不会综合入账至集团的财务报表。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)拟收购上海华茂药业有限公司30%股权","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191587767","title":"康臣药业回购11.2万股股份，耗资约158.29万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191587767","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191587767?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:46","pubTimestamp":1780566384,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司（01681）于2026年6月4日公告，公司于同日通过香港联交所场内回购普通股112,000股，占现有已发行股本约0.0133%。本次回购的每股价格介乎每股14.02港元至14.22港元，总对价约158.29万港元（约1,582,880港元）。\n本次回购完成后，公司已发行股本变动至840,646,111股，库存股数增至901,000股。回购授权于2026年5月26日获通过，根据该授权，公司可购回股份的总额为84,120,311股。公司确认已遵守相关上市规则和法律法规的规定。\n本公告由公司秘书高海恩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购11.2万股股份，耗资约158.29万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640156526","title":"康臣药业(01681)6月4日斥资158.29万港元回购11.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640156526","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640156526?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:43","pubTimestamp":1780566192,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月4日，该公司斥资158.29万港元回购11.2万股股份，每股回购价14.02-14.22港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158159822","title":"康臣药业回购12.7万股股份，耗资约180.33万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158159822","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158159822?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:51","pubTimestamp":1780487507,"startTime":"0","endTime":"0","summary":"2026年6月3日，康臣药业发布翌日披露报表。公告显示，公司于当日通过香港联交所场内回购普通股股份127,000股，占该次回购前现有已发行股本约0.0151%。每股回购价格介乎港币14.02至14.39港元，合计支付约1,803,299港元。公司表示，此次回购已依据2026年5月26日通过的购回授权进行。公告同时确认，公司已遵照香港联交所证券上市规则及相关法律法规的各项规定。本次公告由公司秘书高海恩签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购12.7万股股份，耗资约180.33万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175271949","title":"康臣药业回购203,000股股份，涉资约291.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175271949","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175271949?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:12","pubTimestamp":1780402371,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年6月2日发布公告，披露公司于同日通过香港联合交易所场内回购股份203,000股，约占当日回购前公司已发行股本的0.0241%。回购价格介乎每股14.20港元至14.39港元，合计耗资约2,915,360港元，折合约291.54万港元。根据公告，本次回购完成后，公司已发行股份数量为840,885,111股，库藏股数量增至662,000股，公司总已发行股数维持于841,547,111股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购203,000股股份，涉资约291.54万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948506","title":"康臣药业(01681)6月2日斥资291.54万港元回购20.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948506","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640948506?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:10","pubTimestamp":1780402203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月2日斥资291.54万港元回购20.3万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182696695","title":"康臣药业5月股份变动月报：当月回购459,000股，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1182696695","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182696695?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:53","pubTimestamp":1780390411,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年6月2日发布截至2026年5月31日止的股份变动月报。本次月报显示，公司法定注册股本为5,000,000,000股，每股面值为0.1港元，总额维持5亿港元，与上月持平。报告期末，公司已发行股份总数为841,547,111股，其中不含库存股份的发行股数为841,088,111股，库存股份数量为459,000股。被购回股份由公司持作库存股份，尚未注销。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167785468","title":"康臣药业回购11.5万股股份，涉资约160.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167785468","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167785468?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:51","pubTimestamp":1779976302,"startTime":"0","endTime":"0","summary":"2026年5月28日，康臣药业在公告中披露，该公司于同日于香港联交所场内回购股份，总数为115,000股，占回购前公司已发行股本841,203,111股的约0.0137%。回购价格介乎每股港币13.88元至14.01元，总交易金额约160.61万港元。上述股份回购后，公司已发行股本变更为841,088,111股，库藏股数增至459,000股，合计股份数维持在841,547,111股。康臣药业同时披露，此次股份回购已根据公司于2026年5月26日通过的购回授权进行，该授权允许回购的股份总数为84,120,311股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购11.5万股股份，涉资约160.61万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638998699","title":"康臣药业(01681)5月28日斥资160.61万港元回购11.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638998699","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638998699?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:48","pubTimestamp":1779976130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年5月28日，该公司斥资160.61万港元回购11.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638950764","title":"康臣药业(01681)拟执行股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2638950764","media":"智通财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638950764?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:57","pubTimestamp":1779883070,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业 发布公告，公司决定透过行使公司股东于2026年5月26日举行的股东周年大会上授予董事局回购公司股份的一般授权执行股份回购计划。可用予进行建议回购股份的资金总数：最多2亿港元。董事局相信，取决于当时的市况及筹资安排，股份回购计划符合公司长期发展战略。实施股份回购计划将会优化公司资本结构的管理，符合公司和其股东的整体利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110962839","title":"康臣药业5月22日回购19.2万股，耗资约277.22万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110962839","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110962839?lang=zh_cn&edition=full","pubTime":"2026-05-22 19:02","pubTimestamp":1779447738,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年5月22日发布翌日披露报表，宣布在香港联交所场内回购普通股192,000股，占该回购前已发行股本约0.0228%。本次回购每股价格区间介乎每股14.36港元至14.49港元，平均回购价约每股14.4386港元，总金额约277.22万港元。回购的股份将作为库藏股份持有。公告显示，本次回购完成后，公司于2026年5月22日的已发行股本为841,203,111股，库藏股份数增至344,000股。公司确认已遵守香港联交所上市规则及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业5月22日回购19.2万股，耗资约277.22万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637380159","title":"康臣药业(01681)5月21日斥资147.31万港元回购10.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637380159?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:06","pubTimestamp":1779361586,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年5月21日，该公司斥资147.31万港元回购10.2万股股份，每股回购价14.37-14.47港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196016759","title":"康臣药业5月21日回购10.20万股，涉资约147.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196016759","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196016759?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:05","pubTimestamp":1779361545,"startTime":"0","endTime":"0","summary":"康臣药业于公告中披露，2026年5月21日在香港联交所场内购回公司股份102,000股，占该次回购前公司已发行股本约0.0121%。回购价格区间介乎每股14.37港元至14.47港元，共支付约1,473,050港元，折合约147.31万港元。本次交易完成后，公司已发行股本为841,395,111股，库藏股总数增至152,000股，已发行股份总数保持为841,547,111股。公司同时表示，在本次回购完成后至2026年6月20日，依据相关规则将不会进行新的股份发行或库藏股出售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业5月21日回购10.20万股，涉资约147.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133174750","title":"康臣药业回购5万股股份，耗资约72.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133174750","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133174750?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:32","pubTimestamp":1779273125,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司2026年5月20日公告，已于同日回购普通股合计50,000股，占当日前已发行股本约0.0059%。此次回购每股价格介乎港币14.39元至14.45元，总涉资721,010港元，折合约72.10万港元。回购完成后，公司已发行股本变为841,497,111股，库藏股为50,000股。截至目前，已购回13,730,000股，占购回授权通过当日已发行股本总数的约16.129%。公司在公告中确认，所有程序均已符合香港联合交易所有限公司证券上市规则及相关法律法规的要求。公告由公司秘书高海恩签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购5万股股份，耗资约72.10万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636484521","title":"康臣药业(01681)5月20日斥资72.1万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636484521","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636484521?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:29","pubTimestamp":1779272983,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年5月20日该公司斥资72.1万港元回购5万股，回购价格为每股14.39-14.45港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105671593","title":"康臣药业更新2026年4月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1105671593","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105671593?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:50","pubTimestamp":1777884655,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年5月4日披露了截至2026年4月30日的证券变动月报表，显示报告期内公司股本结构保持稳定，已发行股本和注册股本均未发生增减变化。在股份期权及激励计划方面，公告指出，截至4月末，2013年12月采纳的购股权计划下余额由7,074,153份减少为0，该变动并未引发任何新股发行或相关股份转让。2024年5月采纳的另一项购股权计划虽然本月并无新增期权，但公告披露其尚有84,281,191股潜在可行使期权额度。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632046326","title":"打造“肾科旗舰”领先竞争优势，康臣药业(01681)估值重构进行时","url":"https://stock-news.laohu8.com/highlight/detail?id=2632046326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632046326?lang=zh_cn&edition=full","pubTime":"2026-05-03 17:30","pubTimestamp":1777800600,"startTime":"0","endTime":"0","summary":"4月21日，康臣药业于深圳举办港股通标的庆典暨投资者交流会，在这次活动中，董事局主席、总裁安猛以及多位核心高管分享了公司业务表现和战略规划，并就公司未来增长潜力与投资者进行了深入的探讨。3月9日，根据港股通标的调整通告，42家企业被新调入港股通名单，康臣药业便是其中之一。可见，当前资本市场对康臣药业的定价依然存在显著的认知差与估值错位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177213883","title":"康臣药业(01681)2025年报：收入同比增15.2%至34.17亿元 股东应占溢利增长18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177213883","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177213883?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:25","pubTimestamp":1777368342,"startTime":"0","endTime":"0","summary":"康臣药业在2025年度整体经营稳健上行，收入同比增长15.2%至约人民币34.17亿元，股东应占溢利约人民币10.78亿元，同比上升18.4%，总资产规模较上年末增长至人民币64.10亿元，反映综合实力和盈利能力进一步提升。对比剂业务收入约人民币1.88亿元，同比增长10.9%，新老产品在多省集采及学术推广项目中均取得进展。妇儿药板块实现销售约人民币3.76亿元，同比增长4.0%，以病例库编纂和学术活动为抓手，进一步提升了在围产及妇儿领域的市场影响力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)2025年报：收入同比增15.2%至34.17亿元 股东应占溢利增长18.4%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":-0.0727},{"period":"3month","weight":-0.1662},{"period":"6month","weight":-0.0378},{"period":"1year","weight":0.2581},{"period":"ytd","weight":-0.0852}],"compareEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0604},{"period":"1year","weight":0.0101},{"period":"ytd","weight":-0.0477}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家主要从事药品生产及销售业务的公司。该公司通过两个部门开展业务。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。玉林制药分部主要从事生产及销售传统中成药业务。该公司的产品主要包括肾科药物、妇儿药物、对比剂、骨科药物、皮肤科药物、肝胆药物和其他。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.045449},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016847},{"month":3,"riseRate":0.461538,"avgChangeRate":0.017193},{"month":4,"riseRate":0.692308,"avgChangeRate":0.059405},{"month":5,"riseRate":0.538462,"avgChangeRate":0.023099},{"month":6,"riseRate":0.461538,"avgChangeRate":0.003363},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010504},{"month":8,"riseRate":0.583333,"avgChangeRate":0.012739},{"month":9,"riseRate":0.583333,"avgChangeRate":0.028359},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025966},{"month":11,"riseRate":0.5,"avgChangeRate":0.008692},{"month":12,"riseRate":0.583333,"avgChangeRate":0.021375}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}